Tags

Type your tag names separated by a space and hit enter

Folic acid supplement use in the prevention of neural tube defects.
Ir Med J 2011; 104(1):12-5IM

Abstract

In 2008, planned folic acid fortification for the prevention of Neural Tube Defects (NTD) was postponed. Concurrently, the economic recession may have affected dietary folic acid intake, placing increased emphasis on supplement use. This study examined folic acid supplement use in 2009. A cross-sectional survey of 300 ante-natal women was undertaken to assess folic acid knowledge and use. Associations between demographic, obstetric variables and folic acid knowledge and use were examined. A majority, 284/297 (96%), had heard of folic acid, and 178/297 (60%) knew that it could prevent NTD. Most, 270/297 (91%) had taken it during their pregnancy, but only 107/297 (36%) had used it periconceptionally. Being older, married, planned pregnancy and better socioeconomic status were associated with periconceptional use. Periconceptional folic acid use in 2009 was very low, little changed from economic status were associated with periconceptional use. Periconceptional folic acid use in 2009 was very low, little changed from earlier years. Continuous promotion efforts are necessary. Close monitoring of folic acid intake and NTD rates is essential, particularly in the absence of fortification.

Authors+Show Affiliations

RCSI, 123 St Stephen's Green, Dublin 2.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Multicenter Study

Language

eng

PubMed ID

21387878

Citation

Delany, C, et al. "Folic Acid Supplement Use in the Prevention of Neural Tube Defects." Irish Medical Journal, vol. 104, no. 1, 2011, pp. 12-5.
Delany C, McDonnell R, Robson M, et al. Folic acid supplement use in the prevention of neural tube defects. Ir Med J. 2011;104(1):12-5.
Delany, C., McDonnell, R., Robson, M., Corcoran, S., Fitzpatrick, C., & De La Harpe, D. (2011). Folic acid supplement use in the prevention of neural tube defects. Irish Medical Journal, 104(1), pp. 12-5.
Delany C, et al. Folic Acid Supplement Use in the Prevention of Neural Tube Defects. Ir Med J. 2011;104(1):12-5. PubMed PMID: 21387878.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Folic acid supplement use in the prevention of neural tube defects. AU - Delany,C, AU - McDonnell,R, AU - Robson,M, AU - Corcoran,S, AU - Fitzpatrick,C, AU - De La Harpe,D, PY - 2011/3/11/entrez PY - 2011/3/11/pubmed PY - 2011/4/8/medline SP - 12 EP - 5 JF - Irish medical journal JO - Ir Med J VL - 104 IS - 1 N2 - In 2008, planned folic acid fortification for the prevention of Neural Tube Defects (NTD) was postponed. Concurrently, the economic recession may have affected dietary folic acid intake, placing increased emphasis on supplement use. This study examined folic acid supplement use in 2009. A cross-sectional survey of 300 ante-natal women was undertaken to assess folic acid knowledge and use. Associations between demographic, obstetric variables and folic acid knowledge and use were examined. A majority, 284/297 (96%), had heard of folic acid, and 178/297 (60%) knew that it could prevent NTD. Most, 270/297 (91%) had taken it during their pregnancy, but only 107/297 (36%) had used it periconceptionally. Being older, married, planned pregnancy and better socioeconomic status were associated with periconceptional use. Periconceptional folic acid use in 2009 was very low, little changed from economic status were associated with periconceptional use. Periconceptional folic acid use in 2009 was very low, little changed from earlier years. Continuous promotion efforts are necessary. Close monitoring of folic acid intake and NTD rates is essential, particularly in the absence of fortification. SN - 0332-3102 UR - https://www.unboundmedicine.com/medline/citation/21387878/Folic_acid_supplement_use_in_the_prevention_of_neural_tube_defects_ L2 - http://www.diseaseinfosearch.org/result/8992 DB - PRIME DP - Unbound Medicine ER -